No hay productos en el carrito



Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors
Pacak, K. — Taïeb, D.
1ª Edición Enero 2017
Inglés
Tapa dura
484 pags
1000 gr
17 x 24 x null cm
ISBN 9783319460369
Editorial HUMANA PRESS
LIBRO IMPRESO
-5%
166,39 €158,07 €IVA incluido
159,99 €151,99 €IVA no incluido
Recíbelo en un plazo de
2 - 3 semanas
LIBRO ELECTRÓNICO
-5%
114,39 €108,67 €IVA incluido
109,99 €104,49 €IVA no incluido
Acceso On Line
Inmediato
Description
- A unique presentation of novel functional radionuclide imaging and therapies for the location and treatment of neuroendocrine tumors
- Discusses embryology and classification, molecular genetics, physics and technology in addition to the most up-to-date radiology and management strategies
- Represents a collaborative effort endocrinologists, radiologists, oncologists, geneticists and surgeons
Based on the most novel approaches and cutting-edge clinical and scientific information regarding radionuclide imaging and therapies for neuroendocrine tumors, this clinical guidebook represents a unique collaborative effort between endocrinologists, nuclear physicians, oncologists, surgeons, physicists, radio-pharmacists and geneticists. It begins with the embryology, classification and molecular genetics of gastroenteropancreatic neuroendocrine tumors and carcinoids, chromaffin cell tumors, and MEN1- and MEN2-related tumors. Following a chapter on radiopharmaceuticals in neuroendocrine imaging, it turns to the physics and technology of current and cutting-edge radiology, including SPECT/CT and PET/CT and PET/MR. Discussing of radionuclide imaging covers the tumors mentioned above, as well as pulmonary and thymic neuroendocrine tumors and medullary thyroid carcinoma. A presentation of radionuclide therapies follows, including 131I-MIBG therapy, somatostatin receptor-based therapy, and alpha radionuclide therapy, as well as the role of nanoparticles.
Comprehensive and up-to-date, Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors will assist and guide physicians who encounter patients with these conditions, either from a diagnostic or therapeutic standpoint, and particularly emphasizes the current and emerging medical devices and imaging and therapeutic options.
Karel Pacak, MD, PhD, DSc, Senior Investigator and Chief, Section on Medical Neuroendocrinology, Professor of Medicine, Eunice Kennedy Shriver NICHD/NIH, Bethesda, MD, USA
David Taieb, MD, PhD, Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France
© 2025 Axón Librería S.L.
2.149.0